BRANCH ATHEROMATOUS DISEASE
Clinical trials for BRANCH ATHEROMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new BRANCH ATHEROMATOUS DISEASE trials appear
Sign up with your email to follow new studies for BRANCH ATHEROMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to stop stroke worsening
Disease control CompletedThis study tested whether adding a short-term drug called tirofiban to standard aspirin therapy could better prevent a stroke from getting worse in the first week and reduce the risk of another stroke within 90 days. It involved 970 adults in China who had recently experienced a …
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE4 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
New drug tested to stop stroke worsening and improve recovery
Disease control CompletedThis study tested whether a drug called tirofiban, given within 48 hours of a specific type of stroke, helps patients recover better than standard antiplatelet therapy. It involved 516 adults with a stroke caused by branch atheromatous disease (BAD), which often gets worse early …
Matched conditions: BRANCH ATHEROMATOUS DISEASE
Phase: PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC